新しい診断と治療のABC42/循環器6 大動脈瘤・大動脈解離 改訂第2版

出版社： 最新医学社
著者：
発行日： 2013-10-25
分野： 臨床医学：一般  >  雑誌
ISSN： 03708241
電子書籍版： 2013-10-25 （改訂第2版）
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

4,400 円(税込)

購入する

商品紹介

本誌では我が国の大動脈瘤・大動脈解離に対する先進的な医療の状況，さらに世界における位置づけをお伝えし，実地医療の先生方に対して少しでもお役にたてばと考えております．この分野の成書として是非ご一読ください．

目次

  • 表紙
  • 監修
  • 序
  • MAP 眼で見る大動脈解離・大動脈瘤
  • 目次
  • 執筆者
  • 第1章 疫学
  • 国内外のレジストリー研究
  • 急性大動脈スーパーネットワーク
  • 第2章 病理・病態生理
  • 大動脈瘤・大動脈解離の病理
  • 大動脈解離の病因・病態
  • 胸部大動脈瘤 (病因・病態生理)
  • 腹部大動脈瘤 (病因・病態生理)
  • その他の大動脈瘤 (病因・病態生理)
  • マルファン症候群 (類縁疾患)
  • その他の遺伝性大動脈瘤・大動脈解離 -血管型エーラス・ダンロス症候群-
  • 第3章 診断
  • 急性大動脈症候群の鑑別診断
  • 大動脈解離・大動脈瘤バイオマーカー
  • 画像診断 (CT/MRI)
  • 画像所見 (エコー)
  • 第4章 管理・治療
  • 大動脈解離 (急性期管理・治療)
  • 大動脈瘤・大動脈解離治療のための画像診断
  • 大動脈解離に対する血管内治療 : 急性大動脈解離に対しての急性期血管内治療 (ステント・フェネストレーション)の適応と実際
  • 内科治療 (予後・問題点・今後)
  • 急性大動脈解離のリハビリテーション
  • 外科療法 (open aortic repair)
  • 外科治療 (合併症とその予防)
  • Thoracic endovascular aortic repair (TEVAR)
  • 1. 総論一般
  • 2. Complex TAA
  • 3.他科との集学的治療
  • Endovascular aortic repair (EVAR)
  • 1. 総論一般
  • 2. 胸腹部大動脈瘤に対しての(枝付)ステント治療: その進歩と適応・成績
  • 胸部大動脈瘤のハイブリッド治療
  • 外科治療 (予後・問題点)
  • マルファン症候群の経過・治療・予後
  • 1. 内科治療
  • 2. 外科治療
  • 第5章 ガイドライン
  • 大動脈疾患治療をどう考える -ステントか外科治療か-
  • 略語集
  • 奥付

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1章 疫学

P.24 掲載の参考文献
1) Hagan P G, et al:The International Registry of Acute Aortic Dissection (IRAD):new insights into an old disease.JAMA 283:897-903, 2000.
PubMed
2) Hsue P Y, et al:Acute aortic dissection related to crack cocaine. Circulation 105:1592-1595, 2002.
PubMed
3) Eagle K A, et al:Cocaine-related aortic dissection in perspective. Circulation 105:1529-1530, 2002.
PubMed
4) Mehta R H, et al:Predicting death in patients with acute type A aortic dissection. Circulation 105:200-206, 2002.
PubMed
5) Nienaber C A, et al:Gender-related ditferences in acute aortic dissection. Circulation 109:3014-3021, 2004.
PubMed
6) Tsai T T, et al:Long-term survival in patients presenting with type A acute aortic dissection:insights from the International Registry of Acute Aortic Dissection (IRAD) Circulation 114:1350-1356, 2006.
 
7) Suzuki T, et al:Clinical profiles and outcomes of acute type B aortic dissection in the current era:lessons from the International Registry of Aortic Dissection (IRAD). Circulation 108 (Suppl. 1):II312-II317, 2003.
 
8) Tsai T T, et al:Long-term survival in patients presenting with type b acute aortic dissection. insights from the International Registry of Acute Aortic Dissection. Circulation 114:2226-2231, 2006
PubMed
9) Nienaber C A, et al:Aortic intramural haematoma:natural history and predictive factors for complications. Heart 90:372-374, 2004.
PubMed
10) Nienaber C A, et al:Aortic dissection:new frontiers in diagnosis and management:part II:therapeutic management and follow-up. Circulation 108:772-778, 2003.
PubMed
11) Evangelista A, et al:Acute intramural hematoma of the aorta:amystery in evolution. Circulation 111:1063-1070, 2005.
PubMed
12) Moore A G, et al:Choice of computed tomography, transesophageal echocardiography, magnetic resonance imaging, and aortography in acute aortic dissection:International Registry of Acute Aortic Dissection (IRAD). Am J Cardiol 89:1235-1238, 2002.
PubMed
13) Tsai T T, et al:Partial thrombosis of the false lumen in patients with acute type B aortic dissection. N Engl J Med 357:349-359, 2007.
PubMed
14) Pape LA, et al:Aortic diameter ≧5.5 cm Is not a good predictor of type A aortic dissection:observations from the International Registry of Acute Aortic Dissection (IRAD). Circulation 116:1120-1127, 2007.
 
15) Suzuki T, et al:Type-selective benefits of medication in treatment of acute aortic dissection (from the International Registry of Acute Aortic Dissection [IRAD]). Am J Cardiol 109:122-127, 2012.
PubMed
P.34 掲載の参考文献
1) 高本眞一, 他:循環器病の診断と治療に関するガイドライン (2010年度合同研究班報告):大動脈瘤・大動脈解離診療ガイドライン (2011年改訂版). http://www.j-circ.or.jp/guideline/pdf/ JCS2011_takamot_h.pdf
 
2) Olsson C, et al:Thoracic aortic aneurysm and dissection:increasing Prevalence and improved outcomes reported in a nationwide population-based study of more than 14000cases from 1987 to 2002. Circulation 114:2611-2618, 2006.
 
3) Dominic P J, et al:Population-based study of incidence and outcome of acute aortic dissection and premorbid risk factor control. 10-year results from the Oxford Vascular Study. Circulation 127:2031-2037, 2013.
 
4) 村井達哉:大動脈解離と突然死:東京都監察医務院ににおける1320剖検例の統計的研究. 日法医誌42:564-577, 1988.
 
5) Moriwaki Y, et al:Etiology of out-of-hospital cardiac arrest diagnosed via detailed examinations including perimortem computed tomography. J Emerg Trauma Shock 6 (2):87-94, 2013.
PubMed

第2章 病理・病態生理

P.41 掲載の参考文献
1) Nakashima Y, et al:Alterations of elastic architecture in human aortic dissecting aneurysm. Lab Invest 62 (6):751-760, 1990.
PubMed
2) Dingemans K P, et al:Extracellular matrix of the human aortic media:an ultrastructural histochemical and immunohistochemical study of the adult aortic media. Anat Rec 258 (1):1-14, 2000.
PubMed
3) Clark J M, et al:Transmural organization of the arterial media. The lamellar unit revisited. Arteriosclerosis 5 (1):19-34, 1985.
 
4) 中島豊:大動脈瘤の病理. 臨と研75 (9):1897-1901, 1998.
 
5) 高本眞一, 他:大動脈瘤・大動脈解離診療ガイドライン (2006年改訂版). Circ J 70 (Suppl IV):1569-1646, 2006.
 
6) Nakashima Y, et al:Dissecting aneurysm:a clinicopathologic and histopathologic studyof 111 autopsied cases. Hum Pathol 21 (3):291-296, 1990.
 
7) Nakashima Y:Pathogenesis of aortic dissection:Elastic fiber abnormalities and aoriic medial weakness. Ann Vasc Dis 3 (1):28-36, 2010.
PubMed
8) Nakashima Y, et al:Alteration of elastic architecture in the lathyritic rat aorta implies the pathogenesis of aortic dissectinganeurysm. Am J pathol 140 (4):959-969, 1992.
 
9) Akutsu K, et al:Genetic analysis of young adult patients with aortic disease not fulfilling the diagnostic criteria for Marfan syndrome. Circ J 74 (5):990-997, 2010.
 
10) Maleszewski J J, et al:Histopathologic findings in ascending aortas from individualswith Loeys-Dietz syndrome (LDS). Am J Surg Pathol 33 (2):194-201, 2009.
 
P.50 掲載の参考文献
1) Saraff K, et al:Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 23:1621-1626, 2003.
PubMed
2) Habashi J P, et al:Losartan, an ATI antagonlst, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312:117-121, 2006.
 
3) Holm T M, et al:Noncanonical TGFbeta signaling contributes to aortic aneurysm progression in Marfan syndrome mice. Science 332:358-361, 2011.
PubMed
4) Brooke B S, et al:Angiotensin II blockade and aortic-root dilation in Marfan:s syndrome. N Engl J Med 358:2787-2795, 2008.
PubMed
5) Maki J, et al:Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice. Circulation 106:2503-2509, 2002.
PubMed
6) Kleinewietfeld M, et al:Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature 496:518-522, 2013.
PubMed
7) Wu C, et al:Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature 496:513-517, 2013.
PubMed
P.56 掲載の参考文献
1) Isselbacher E M:Thoracic and abdominal aortic aneurysm. Circulation 111:816-828, 2005.
PubMed
2) Ito S, et al:Differences in atherosclerotic profiles between patients with thoracic and abdominal aortic aneurysms. Am J Cardiol 101 (5):696-699, 2008
PubMed
3) Lesauskaite V, et al:Expression of matrix metalloproteinase, their tissue inhibitors, and osteopontin in the wall of thoracic and abdominal aorta with dilatative pathology. Hum Pathol 37 (8):1076-1084, 2006.
PubMed
4) Sueyoshi E, et al:Aortic aneurysms in patients with Takayasu's arteritis:CT evaluation. AJR Am J Roentgenol 175 (6):1727-1733, 2000.
PubMed
5) Garg V, et al:Mutations in NOTCHI cause aortic valve disease. Nature 437:270-274, 2005.
 
6) Coady M A, et al:What is the appropriate size criterion for resection of thoracic aortic aneurysms? J Thorac Cardiovasc Surg 113 (3):476-489, 1997.
PubMed
7) Davies R R, et al:Yearly rupture or dissection rates for thoracic aortic aneurysms:simple prediction based on size. Ann Thorac Surg 73 (1):17-27, 2002,
 
8) Coady M A, et al:Surgical intervention criteria for thoracic aortic aneurysms:astudy of growth rates and complications. Ann Thorac Surg 67 (6):1922-1926, 1999.
 
9) Akutsu K, et al:Genetic analysis of young adult patients with aortic disease not fulfilling the diagnostic criteria for Marfan syndrome. Circ J 74:990-997, 2010.
 
10) Coady M A, et al:Familial patterns of thoracic aortic aneurysms. Arch Surg 134:361-367, 1999.
PubMed
11) Faivre L, et al:Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBNI mutations:an international study. Am J Hum Genet 81:454-466, 2007.
PubMed
12) Morisaki H, et al:Mutation of ACTA2 gene as an important cause of familial and non-familial non-syndromatic thoracic aortic aneurysm and/or dissection. Hum Mutat 30:1406-1411, 2009.
PubMed
13) Oderich G S, et al:The spectrum, management and clinical outcome of Ehlers-Danlossyndrome type IV:a 30-year experience. J Vasc Surg 42:98-106, 2005.
 
14) Zhu L, et al:Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus. Nat Genet 38:343-349, 2006.
 
15) van de Laar IM, et al:Phenotypic spectrum of the SMAD3-related aneurysms-osteoarthritis syndrome. J Med Genet 49:47-57, 2012.
PubMed
16) Lin A E, et al:Aortic dilation, dissection, andrupture in patients with Turner syndrome, J Pediatr 109:820-826, 1986.
 
P.63 掲載の参考文献
1) 日本循環器学会:大動脈瘤・大動脈解離診療ガイドライン (2011年改訂版)
 
2) Li Z Y, et al:Association between aneurysm shoulder stress and abdominal aortic aneurysm expansion. Circulation 122:1815-1822, 2010.
PubMed
3) Koch A E, et al:Human abdominal aortic aneurysms:immunophenotypic analysis suggesting an immune-mediated response. Am J Pathol 137:1199-1213, 1990.
PubMed
4) Freestone T, et al:Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 15:1145-1151, 1995.
PubMed
5) Anidj ar S, et al:Correlation of infiammatory infiltrate with the enlargement of experimental aortic aneurysms. J Vasc Surg 16:139-147, 1992.
 
6) Slaiby JM, et al:Expansion of aortic aneurysms is reduced by propranolol in a hypertensive rat model. J Vasc Surg 20:178-183, 1994.
 
7) Moore G, et al:Suppression of experimental abdominal aortic aneurysms by systemic treatment with a hydroxamate-based matrix metalloproteinase inhibitor (RS132908). J Vasc Surg 29:522-532, 1999.
PubMed
8) Miralles M, et al:Indomethacin inhibits expansion of experimental aortic aneurysms via inhibition of the cox2 isoform of cyclooxygenase. J Vasc Surg 29:884-893, 1999.
PubMed
9) Hoshina K, et al:Wall shear stress and strain modulate experimental aneurysm cellularity. J Vasc Surg 37:1067-1074, 2003.
PubMed
10) Hoshina K, et al:Aortic cell proliferation via basic fibroblast growth factor gene transfer limits progression of experimental abdominal aortic aneurysm. J Vasc Surg 40:512-518, 2004.
PubMed
11) Curch J A, et al:Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metallo-proteinases in patietns with abdominal aortic aneurysms. J Vasc Surg 31:325-342, 2000.
 
12) Halloran B G, et al:Localization of aortic disease is associated with intrinsic differences in aortic structure. J Surg Res 59:17-22, 1995.
PubMed
13) Wolinsky H, et al:Comparison of abdominal and thoracic aortic medial structure in mammals:deviation of man from the usual pattern. Circ Res 25:677-686, 1969.
PubMed
14) Johansen K, et al:Familial tendency for abdominal aortic aneurysms. JAMA 256:1934-1936, 1986.
PubMed
15) Verloes A, et al:Aneurysms of the abdominal aorta:familial and genetic aspects in three hundred thirteen pedigrees. J Vasc Surg 21:646-655, 1995.
PubMed
16) 宮田哲郎:厚生労働科学研究費補助金難治性疾患克服研究事業 急性大動脈症候群に対する予防治療の指針作成に向けた基礎研究 平成22～23年度総合研究報告書, 2012.
 
17) Lederle F A, et al:Prevalence and associations of abdominal aortic aneurysm detected through screeningr Aneurysm Detectionand Management (ADAM) Veterans Affairs Cooperative Study Group. Ann Intern Med 126:441-449, 1997.
 
18) Chang J B, et al:Risk factors associated with rapid growth of small abdominal aortic aneurysms. Surgery 121:117-122, 1997.
PubMed
19) MacSweeney, et al:Smoking and growthrate of small abdominal aortic aneurysms. Lancet 344:651-652, 1994.
 
20) Brady AR, et al:Abdominal aortic aneurysm expansion. Risk factors and time intervals for surveillance. Circulation 110:16-21, 2004.
PubMed
21) Vega de Ceniga M, et al:Growth rate and associated factors in small abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 31:231-236, 2006.
PubMed
22) Cronenwett J L, et al:Actuarial analysis of variables associated with rupture of small abdominal aortic aneurysms. Surgery 98:472-483, 1985.
PubMed
23) Sterpetti A V, et al:Factors influencing the rupture of abdominal aortic aneurysm. Surg Obstet Gynecol 173:175-178, 1991.
PubMed
24) Rutherford R B, et al:Suggested standards frr reporting on arterial aneurysms. J Vasc Surg 13:444-450, 1991.
 
25) Reed W L, et al:Learning from the last ultrasound. A population-based study of patients with abdominal aortic aneurysm. Arch Intern Med 157:2064-2068, 1997.
 
26) Hallin A, et al:Literature review of surgical management of abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 22:197-204, 2001.
PubMed
27) Santili S M, et al:Expansion rates and outcomes for the 3.O cm to the 3.9 cm infrarenal abdominal aortic aneurysm. J Vasc Surg 35:666-671, 2002.
 
28) Fisher D F Jr, et al:Preoperative disseminated intravascular coagulation associated with aortic aneurysms. A prospective study of 76 cases. Arch Surg 118:1252-1255, 1983.
PubMed
P.75 掲載の参考文献
1) 由谷親夫:血管炎症候群の病理. 病理と臨9:1007-1013, 2003.
 
2) 高安右人:奇異なる網膜中心血管の変化の一例. 日眼会誌12:554-555, 1908.
 
3) Zhu F P, et al:Takayasu arteritis:imaging spectrum at multidetector CT angiography. Br J Radiol 85 (1020):1282-1292, 2003.
 
4) Hellmann D B:Immunopathogenesis, diagnosis, and treatment of giant cell arteritis, temporal arteritis, polymyalgia rheumatica, and Takayasu's arteritis. Curr Opin Rheumatol 5(1):25-32, 2003.
 
5) Gonzalez-Gay M A, et al:Giant cell arteritis:epidemiology, diagnosis, and management Curr Rheumatol Rep 12 (6):436-442, 2010.
PubMed
6) Hunder G G, et al:The American College of Rheumatology 1990 Criteria for the Classification of Giant Cell Arteritis. Arthritis Rheum 33:1122-1128, 1990
PubMed
7) 川崎富作:指趾の特異的落屑を伴う小児の急性熱性皮膚粘膜・淋巴腺症候群 (自検例50例の臨床的観察). アレルギー16:38-86, 1967.
 
8) Tanaka N, et al:Kawasaki disease. Arch Pathol Lab med 100:81-86, 1976.
PubMed
9) 加藤裕久, 他:川崎病による冠状動脈瘤. 臨科学30:563-569, 1994.
 
10) Ishizaka N, et al:Infected aortic aneurysm and inflammatory aortic aneurysmin search of an optimal differential diagllosis. J Cardiol 59 (2):123-131, 2012.
PubMed
11) Masuda J, et al:Atheromatous embolism in the brain. Neurology 44:1231-1237, 1994.
PubMed
12) Walker D I et al:Inflammatory aneurysms of the abdominal aorta Br J Surg 59:609-614, 1972.
PubMed
13) Kamisawa T, et al:IgG4-related sclerosing disease. World J Gastroenterol 14:3948-3955, 2008.
PubMed
14) Kasashima S, et al:IgG4-related inflammatory abdominal aortic aneurysm. Curr Opin Rheumatol 23 (1):18-23, 2011.
PubMed
15) Kasashima S, et al:A new clinicopathological entity of IgG4-related inflammatory abdominal aortic aneurysm. J Vasc Surg 49 (5):1264-1271, 2009.
PubMed
16) Zen Y, et al:Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology 45:1538-1546, 2007.
PubMed
17) Kasashima S, et al:A clinicopathologic study of immunoglobulin G4-related sclerosing disease of the thoracic aorta. J Vasc Surg 52 (6):1587-1595, 2010.
PubMed
18) Yoshida M, et al:Report of a case. Surg Today 37:794-797, 2007.
PubMed
19) Kasashima S, et al:A clinicopathologic study of immunoglobulin G4-related disease of the femoral and popliteal arteries in the spectrum of immunoglobulin G4-related periarteritis. J Vasc Surg 57 (3) 816-822, 2013.
PubMed
P.83 掲載の参考文献
1) Judge D P, et al:Marfan:s syndrome. Lancet 366 (9501):1965-1976, 2005.
PubMed
2) Robinson P N, et al:The molecular genetics of Marfan syndrome and related disorders. J Med Genet 43 (10):769-787, 2006.
PubMed
3) Dietz H C, et al:Marfan syndrome caused by a recurrent do novo missense mutation in the fibrillin gene. Nature 352 (6333):337-339, 1991.
PubMed
4) Faivre L, et al:Effect of mutation type and location on clinical outcome and FBNI mutations:An international study in 1,013 probands with Marfan syndrome or related phenotypes. Am J Hum Genet 81 (9):454-466, 2007.
 
5) Neptune E R, et al:Dysregulation of TGF-β activation contributes to pathogenesis of Marfan syndrome. Nat Genet 33 (3):407-411, 2003.
 
6) Mizuguchi T, et al:Heterozygous TGFBR2 mutations in Marfan syndrome. Nat Genet 36 (8):855-860, 2004.
PubMed
7) Loeys BL, et al:A syndrome of altered cardiovascular craniofacial, neurocognitive and skeletal development caused by mutations in TGFBRI or TGFBR2. Nat Genet 37 (3):275-281, 2005.
 
8) Habashi J p, et al:Losartan, an ATI antagonlst, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312 (5770):117-121, 2006.
 
9) Van de Laar IMBH, et al:Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis. Nat Genet 43 (2):121-126, 2011.
 
10) Boileau C, et al:TGFB2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of Marfan syndrome. Nat Genet 44 (8):916-921, 2012.
PubMed
11) Lindsay M E et al:TGFB2 Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm. Nat Genet 44 (8):922-927, 2012.
 
12) Doyle A J, et al:Mutations in the TGF-β repressor SKI cause Shprintzen-Goldberg syndrome with aortic aneurysm. Nat Genet 44 (11):1249-1254, 2012.
 
13) Superti-Furga A, et al:Ehlers-Danlos syndrome type IV:amulti-exon deletion in one of the two COL3A1 alleles affecting structure, stability, and processing of type III procollagen. J Biol Chem 263 (13):6226-6232, 1988.
 
14) Coucke P J, et al:Mutations in the facilitative glucose transporter GLUTIO alter angiogenesis and cause arterial tortuosity syndrome. Nat Genet 38 (4):452-457, 2006.
PubMed
15) Guo D C, et al:Mutations in smooth muscle α-actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nat Genet 39 (12):1489-1493, 2007.
 
16) Zhu L, et al:Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus. Nat Genet 38 (3):343-349, 2006.
 
P.92 掲載の参考文献
1) Jain D, et al:Causes and histopathology of ascending aortic disease in children and young adults. Cardiovasc Pathol 20 (1):15-25, 2011.
 
2) Halushka M K:Single gene disorders of the aortic wall. Cardiovasc Pathol 21 (4):240-244, 2012.
PubMed
3) Hoffj an S:Genetic dissection of Marfan syndrome and related connective tissue disorders:an update 2012. Mol Syndromol 3 (2):47-58, 2012.
 
4) Pepin M G, et al:Ehlers-Danlos syndrome, Vascular type. In:GeneReviews at GeneTests:Medical Genetics Information Resource (database online) . Copyright, University of Washington, Seattle, 1993-2013. Available at http://www.ncbi.nlm.nih.gov/books/NBK1116/. Last update, 2011. Accessed July 24, 2013.
 
5) Boutouyrie P, et al:Increased carotid wall stress in vascular Ehlers-Danlos syndrome. Circulation 109 (12):1530-1535, 2004.
PubMed
6) Ong K T, et al:Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome:a prospective randomized, open, blinded-endpoints trial. Lancet 376 (9751):1476-1484, 2010.
PubMed

第3章 診断

P.101 掲載の参考文献
1) Vilacosta I, et al:Acute aortic syndrome. Heart 85 (4):365-368, 2001.
PubMed
2) Akutsu K, et al:A rapid bedside D-dimer assay (cardiac D-dimer) for screening of clinically suspected acute aortic dissection. Cir J 69 (4):397-403, 2005.
 
3) Suzuki T, et al:Diagnosis of acute aortic dissection by D-dimer:the International Registry of Acute Aortic Dissection Substudy on Biomarkers (IRAD-Bio) experience. Circulation 119 (20):2702-2707, 2009.
PubMed
4) Nienaber C A, et al:Intramural hemorrhage of the thoracic aorta. Diagnostic and therapeutic implications. Circulation 92 (6):1465-1472, 1995.
PubMed
5) Mohr-Kahaly S, et al:Aortic intramural hemorrhage visualized by transesophageal echocardiography:findings and prognostic implications. J Am Coll Cardiol 23 (3):658-664, 1994.
PubMed
6) Vilacosta I, et al:Natural history and serial morphology of aortic intramural hematoma:a novel variant of aortic dissection. Am Heart J 134 (3):495-507, 1997.
PubMed
7) Williams D M, et al:Aortic branch artery pseudoaneurysms accompanying aortic dissection. Part II. Distinction from penetrating atherosclerotic ulcers. J Vasc Interv Radiol 17 (5):773-781, 2006.
PubMed
8) Williams D M, et al:Aortic branch artery pseudoaneurysms accompanying aortic dissection. Part I. Pseudoaneurysm anatomy JV asc Interv Radiol 17 (5):765-771, 2006.
 
9) Group J J W:Guidelines for Diagnosis and Treatment of Aortic Aneurysm and Aortic Dissection (JCS 2011) . Cir J 77 (3):789-828, 2013.
 
10) Kaji S, et al:Long-term prognosis of patients with type B aortic intramural hematoma. Circulation 108 (Suppl 1):H307-311, 2003.
 
11) Kaji S, et al:Long-term prognosis of patients with type A aortic intramural hematoma. Circulation 106 (12 Suppl 1):1248-252, 2002.
 
12) Song J K, et al:Different clinical features of aortic intramural hematoma versus dissection involving the ascending aorta. J Am Coll Cardiol 37 (6):1604-1610, 2001.
PubMed
13) Song J K, et al:Different remodeling of descending thoracic aorta after acute event in aortic intramural hemorrhage versus aortic dissection. Am J Cardiol 83 (6):937-941, 1999.
PubMed
14) Kitai T, et al:Impact of new development of ulcer-like projection on clinical outcomes in patients with type B aortic dissection with closed and thrombosed false lumen. Circulation 122 (11 Suppl):S74-80, 2010.
 
15) Stanson A W, et al:Penetrating atherosclerotic ulcers of the thoracic aorta:natural history and clinicopathologic correlations. Ann Vasc Surg 1 (1):15-23, 1986.
PubMed
16) Ganaha F, et al:Prognosis of aortic intramural hematoma with and without penetrating atherosclerotic ulcer:a clinical and radiological analysis. Circulation 106 (3):342-348, 2002.
PubMed
17) Vilacosta I, et al:Penetrating atherosclerotic aortic ulcer:documentation by transesophageal echocardiography. J Am Coll Cardiol 32 (1):83-89, 1998.
PubMed
18) Hiratzka LF, et al:ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STSSVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease:a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation 121 (13):e266-369, 2010.
 
19) Tittle S L, et al:Midterm follow-up of penetrating ulcer and intramural hematoma of the aorta. J Thorac Cardiovasc Surg 123 (6):1051-1059, 2002.
PubMed
20) Cho K R, et al:Penetrating atherosclerotic ulcer of the descending thoracic aorta and arch. J Thorac Cardiovasc Surg 127 (5):1393-1399, 2004.
 
P.111 掲載の参考文献
1) Suzuki T, et al:Biomarker-assisted diagnosis of acute aorutic dissection:how far we have come and what to expect Curr Opin Cardiol 25:541-545, 2010
PubMed
2) Suzuki T, et al:Diagnosis of acute aortic dissection by D-dimer:the International Registry of Acute Aortic Dissection Sub-study on Biomarkers (IRAD-Bio) experience. Circulation 119:2702-2707, 2009.
 
3) Suzuki T, et al:Circulating Transforming Growth Factor-Beta Levels in Acute Aortic Dissection. J Am Coll Cardiol 58:775, 2011.
PubMed
4) Golledge J, et al:Circulating Markers of Abdominal Aortic Aneurysm Presence and Progression. Circulation 118:2382-2392, 2008.
PubMed
5) Kroner B L, et al:The National Registry of Genetically Triggered Thoracic Aortic Aneurysm and Cardiovascular Conditions (GenTAC):Results from phase I and scientific opportunities in phase II. Am Heart J 162:627-632, 2011.
 
6) Matt P, et al:Circulating Transforming Growth Factor-β in Marfan Syndrome. Circulation 120:526-532, 2009.
 
P.118 掲載の参考文献
1) Hayashi H, et al:Multidetector-row CT evaluation of aortic disease. Radiat Med 23:1-9, 2005.
PubMed
2) 大動脈瘤・大動脈解離診療ガイドライン (2011年度改訂版) . http://www.j-circ.or.jp/guideline/pdf/JCS2011_takamoto_h.pdf
 
3) 日本腎臓学会, 他編:腎障害患者におけるヨード造影剤使用に関するガイドライン2012. 東京医学社, 東京, 2012.
 
4) 腎障害患者におけるガドリニウム造影剤使用に関するガイドライン. http://www.radiology.jp/uploads/photos/649.pdf
 
P.129 掲載の参考文献
1) 吉田 清, 他:循環器超音波検査の適応と判読ガイドライン (2010年改訂版) (http://www.j-circ.or.jp/guideline/pdf/JCS2010yoshida.h.pdf) (2013年7月20日閲覧)
 
2) 大倉宏之:II診断の進歩2エコー. 日内会誌99 (2):258-264, 2010.
 
3) 吉田清:5大動脈疾患. チャートでわかる実践心エコー図法改訂第二版 (吉田清編), p149-154. 南江堂, 東京, 2009.
 
4) Nienaber C A:The role of imaging in acute aortic syndromes. Eur Heart J Cardiovasc Imaging 14:15-23, 2013.
PubMed
5) 大倉宏之:大動脈壁のプラークを診る. Vascular Lab 2012年増刊決定版 超音波検査テクニックマスター頭部・頸部・胸部・上肢編 (松尾 汎 監), p222-227. メディカ出版, 大阪 2012
 

第4章 管理・治療

P.137 掲載の参考文献
1) 村井達哉:大動脈解離と突然死:東京都監察医務院における1320剖検例の統計的研究. 日法医誌42:564-577, 1988
 
2) 2010 ACCF/AHA/AATS/ACR/ASASCA/SCAI/SIR/STS/SVM Guidehnes for the Diagnosis and Management of Patients With Thoracic Aortic Disease:A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation 121:e266-e369, 2010.
 
3) 高本眞一:循環器病の診断と治療に関するガイドライン (2010年度合同研究班報告) 大動脈瘤・大動脈解離診療ガイドライン.(2011年改訂版) www.j-circ.or.jp/guideline/pdf/JCS2011_takamoto_h.pdf
 
4) Nienaber C A, et al:Aortic dissection:new frontiersin diagnosis and management;part therapeutic management and follow-up. Circulation 108:772-778, 2003.
 
5) Kodama K, et al:Tight heart rate control reduces secondary adverse events in patients with type B acute aortic dissection. Circulation 118 (14 Suppl):S167-S170, 2008.
 
6) 静 毅人, 他:急性大動脈解離に合併する急性呼吸不全の発症に関与するC反応性蛋白と好中球エラスターゼの意義. 岩手医学誌 57:137-146, 2005.
 
7) 田林胱一, 他:病態・症候急性大動脈解離と遷延する呼吸障害―胸水か炎症か―. 「大動脈瘤・大動脈解離診療のコツと落とし穴」. 中山書店, 東京, 2006.
 
8) 田林胱一, 他:病態・症候急性大動脈解離と譫妄.「大動脈瘤・大動脈解離診療のコツと落とし穴.中山書店, 東京, 2006.
 
P.149 掲載の参考文献
1) Yoshioka K, et al:MR angiography and CT angiography of the artery of Adamkiewicz:state of the art Radiographics 26 (suppl I):S63-S73, 2006.
 
2) Utsunomiya D, et al:Demonstration of the Adamkiewicz artery in patients with descending or thoracoabdominal aortic aneurysm:optimization of contrast-medium application for 64-detector-row CT angiography. Eur Radiol 18:2684-2690, 2008.
PubMed
3) Yoshioka K, et al:MR angiography and CT angiography of the artery of Adamkiewicz:noninvasive preoperative assessment of thoracoabdominal aortic aneurysm. Radiographics 23:1215-1225, 2003.
PubMed
4) Yamada N, et al:MRA of the Adamkiewicz arteryl a preoperative study for thoracic aortic aneurysm. J Comput Assist Tomogr 24:362-368, 2000.
 
5) Hyodoh H, et al:Usefulness of preoperative detection of artery of Adamkiewicz with dynamic contrast-enhanced MR angiography. Radiology 236:1004-1009, 2005.
PubMed
6) Yoshioka K, et al:Three-dimensional demonstration of the collateral circulation to the artery of Adamkiewicz via internal thoracic artery with 16-row multi-slice CT. Eur J Cardiothorac Surg 28:492, 2005.
 
7) Yoshioka K, et al:Three-dimensional demonstration of the collateral circulation to the artery of Adamkiewicz via thoracodorsal artery with multi-slice computed tomography. Eur J Cardiothorac Surg 37:1234:2010.
 
8) Tanaka R, et al:Intentional preservation of collateral circulation to the artery of Adamkiewicz using axillo-axillary bypass, concomitant with thoracic endovascular aneurysm repair. Eur J Cardiothorac Surg 2013 (Epub ahead of print)
 
9) Yoshioka K, et al:Three-dimensional demonstration of the artery of Adamkiewicz via the thoracodorsal artery and inferior phrenic artery Eur J Cardiothrac Surg 39:137, 2011.
PubMed
10) 星俊子, 他:胸部下行大動脈瘤に対するステントグラフト内挿術によって閉塞されたアダムキュービッツ動脈を分岐する肋間動脈への側副血行路の検討. IVR 会誌 16:43-48, 2011.
 
P.157 掲載の参考文献
1) Hagan P G, et al:The international registry of acute aortic dissection (IRAD). JAMA 283:897-903, 2000.
PubMed
2) Slonim S M, et al:Aortic dissection:percutaneous management of ischemic complications with endovascular stents and balloon fenestration. J Vasc Surg 23:241-251, 1996.
PubMed
3) Williams D M, et al:The dissected aorta:percutaneous treatment of ischemic complications-principles and results. J Vasc Intervent Radiol 8:605-625, 1997.
 
4) Dake M D, et al:Endovascular stent-graft placement for the treatment of acute aortic dissection. N Engl J Med 340:1546-1552, 1999.
PubMed
5) 大動脈瘤・大動脈解離診療ガイドライン (2011年改訂版)
 
6) Trimarchi S, et al:Role and results of surgery in acute type B aortic dissection:insights from the International Registry of Acute Aortic Dissection (IRAD). Circulation 114 (1 Suppl):1357-364, 2006.
 
7) Gurin D, et al:Dissecting aneurysm of the aorta:diagnosis and operative relief of acute arterial obstruction due to this cause. N Y State J Med 35:1200-1202, 1935.
 
8) Eggebrecht H, et al:Endovascular stentgraft placement for complication of acutetype B aortic dissection. Curr Opin Cardiol 20:477-483, 2005.
 
9) Norberto E M, et al:Coil embolization ofpersistent false lumen after stent graft repair of type B aortic dissection. J Vasc Surg 54:201-204, 2011.
 
10) Trimarchi S, et al:Importance of refractorypain and hypertension in acute type B aortic dissection. Circulation 122:1283-1289, 2010.
PubMed
11) Kitai T, et al:Impact of new development of ulcer-like projection on clinical outcomesin patients with type B aortic dissection with closed and thrombosed false lumen. Circulation 122 (Suppl):S74-S80, 2010.
 
12) Nienaber C A, et al:Endovascular repair of type B aortic dissection:long-term results of the randomized investigation of stent grafts in aortic dissection trial. Circ Cardiovasc Interv 6:407-416, 2013.
PubMed
13) Kato M, et al:Determining surgical indications for acute type B dissection based onenlargement of aortic diameter during thechronic phase. Circulation 92 (Suppl):II107-II112, 1995.
 
14) Metcalfe M J, et al:The first endovascular repair of an acute type A dissection using an endograft designed for the ascending aorta. J Vasc Surg 55:220-222, 2012.
PubMed
P.163 掲載の参考文献
1) Meszaros I, et al:Epidemiology and clinicopathology of aortic dissection. Chest 117:1271-1278, 2000.
PubMed
2) Hagan P G, et al:The International Registry of Acute Aortic Dissection (IRAD):new insights into an old disease. JAMA 283:897-903, 2000.
PubMed
3) Suzuki T, et al:Clinical profiles and outcomes of acute type B aortic dissectioin the current era:lessons from the International Registry of Aortic Dissection (IRAD). Circulation 108 (Suppl 1):II312-317, 2003.
 
4) Sakakura K, et al:Determinants of in-hospital death and rupture in patients with a Stanford B aortic dissection. Circ J 71:1521-1524, 2007.
 
5) Tsai T T, et al:Long-term survival in patients presenting with type B acute aortic dissection:insights from the International Registry of Acute Aortic Dissection. Circulation 114:2226-2231, 2006.
PubMed
6) Sakakura K, et al:Determinants of longterm mortality in patients with type B acute aortic dissection. Am J Hypertens 22:371-377, 2009.
PubMed
7) Akutsu K, et al:Effects of the patent false lumen on the long-term outcome of type B acute aortic dissection. Eur J Cardiothorac Surg 26:359-366, 2004.
 
8) Hata M, et al:Optimal treatment of type B acute aortic dissection:long-term medical follow-up results. Ann Thorac Surg 75:1781-1784, 2003.
PubMed
9) Sakakura K, et al:Peak C-reactive protein level predicts long-term outcomes in type Bacute aortic dissection. Hypertension 55:422-429, 2010.
 
10) Guidelines for diagnosis and treatment of aortic aneurysm and aortic dissection OCS 2011)-digest version. Cir J 77:789-828, 2013.
 
11) Takeshita S, et al:Angiotensin-converting enzyme inhibitors reduce long-term aortic events in patients with acute type B aortic dissection. Cir J 72:1758-1761, 2008.
 
12) Kodama K, et al:Tight heart rate control reduces secondary adverse events in patients with type B acute aortic dissection. Circulation 118:S167-170, 2008.
PubMed
13) Genoni M, et al:Chronic beta-blocker therapy improves outcome and reduces treatment costs in chronic type B aortic dissection. Eur J Cardiothorac Surg 19:606-10, 2001.
 
P.170 掲載の参考文献
1) 高本眞一, 他:循環器病の診断と治療に関するガイドライン 大動脈瘤・大動脈解離診療ガイドライン (2011年改訂版). Cir J 77:789-828, 2013.
 
2) 西上和宏, 他:急性期における解離性大動脈瘤の具体的な医療手順に関する調査研究 効果的医療技術の確立推進臨床研究事業. 2003.
 
3) Kodama K, et al:Tight heart rate control reduces secondary adverse events in patients with type B acute aortic dissection. Circulation 118 (14Suppl):S167-170, 2008.
 
P.177 掲載の参考文献
1) 循環器病の診断と治療に関するガイドライン (2010年度合同研究班報告). 大動脈瘤・大動脈解離診断ガイドライン (2011年改訂版).
 
2) Kaji S, et al:Long-term prognosis of patients with type A aortic intramural hematoma. Circulation 106:1248-252, 2002.
 
3) Watanuki H, et al:Is emergency total arch replacement with a modified elephant trunk technique justified for acute type A aortic dissection ? Ann Thorac Surg 84 (5):1585-1591, 2007.
PubMed
4) Uchida N, et al:Long-term results of the frozen elephant trunk technique for extended aortic arch disease. Eur J Cardiothorac Surg 37 (6):1338-1345, 2010.
PubMed
5) Reece T B, et al:Central cannulation is safe in acute aortic dissection repair. JThorac Cardiovasc Surg 133 (2):428-434, 2007,
PubMed
6) Kallenbach K, et al:Evolving strategies for treatment of acute aortic dissection type A. Circulation 110 (11 Suppl 1):II243-249, 2004.
 
P.186 掲載の参考文献
1) Kuwano H, et al:Thoracic and cardiovascular surgery in Japan during 2010-annual report by the Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg 60:680-708, 2012.
PubMed
2) Kouchoukos N T, et al:Hypothermic cardiopulmonary bypass and circulatory arrest in the management of extensive thoracic and thoracoabdominal aortic aneurysms. Semin Thorac Cardiovasc Surg 15:333-339, 2003.
PubMed
3) Griepp R B, et al:Prosthetic replacement of the aortic arch. J Thorac Cardiovasc Surg 70:1051-1063, 1975.
PubMed
4) Kazui T, et al:Selective cerebral perfusion during operation for aneurysms of the aonic arch:a reassessment. Ann Thorac Surg 53:109-114, 1992.
 
5) Ueda Y, et al:Retrograde cerebral perfusion for aortic arch surgery:analysis of risk factors. Ann Thorac Surg 67:1879-1882, 1999.
PubMed
6) Saiki Y, et al:Efficacy of modified hypothermic selective cerebral perfusion techniqueduring thoracic aortic surgery. Low Temp Med 35:6-9, 2009.
 
7) Shimizu H, et al:Current strategies for spinal cord protection during thoracic and thoracoabdominal aortic aneurysm repair. Gen Thorac Cardiovasc Surg 59:155-163, 2011.
PubMed
8) Takase K, et al:Demonstration of the artery Adamkiewicz at multi-detector row helical CT. Radiology 233:39-45, 2002.
 
9) Coselli J S, et al:Cerebrospinal drainage reduces paraplegia following thoracoabdominal aortic aneurysm repair:results of a prospective randomized trial. J Vasc Surg 35:631-639, 2002
 
10) Kunihara T, et al:Naloxone lowers cerebrospinal fluid levels of excitatory amino acids after thoracoabdominal aortic surgery. J Vasc Surg 40:681-690, 2004.
PubMed
P.194 掲載の参考文献
1) Parodi J C, et al:Transfemoral intraluminal graft implantation for abdominal aortic aneurysms. Ann Vasc Surg 5:491-499, 1991.
PubMed
2) Dake M D, et al:Transluminal placement of endovascular stent-grafts for the treatment of descending thoracic aortic aneurysms. N Engl J Med 331:1729-1734, 1994.
PubMed
3) Kato M, et al:New graftimplanting method for thoracic aortic aneurysm or dissection with a stented graft. Circulation 94 (9 Suppl):II188-193, 1996.
PubMed
4) Hiratzka LF, et al:2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease:Executive summary. Circulation 121:1544-1579, 2010.
 
5) 循環器病の診断と治療に関するガイドライン. 大動脈瘤・大動脈解離診療ガイドライン (2011年改訂版). JCS 2011.
 
6) Ishimaru S:Endografting of the Aortic Arch. J Endovasc Ther 11 (Suppl 2):H62-71, 2004.
 
7) Czerny M, et al:Risk factors of mortality in different age groups after thoracic endovascular aortic repair. Ann Thorac Surg 90:534-538, 2010.
PubMed
8) Criado F J, et al:Stent graft repair in the aortic arch and descending thoracic aorta a 4-year experience. J Vasc Surg 36:1121-1128, 2002.
PubMed
9) Piffaretti G, et al:Acute iatrogenic type Aaortic dissection fblowing thoracic aortic endografting. J Vasc Surg 51:993-999, 2010.
 
10) Cambria R P, et al:A multicenter clinicaltrial of endovascular stent graft repair ofacute catastrophes of the descending thoracicaorta. J Vasc Surg 50:1255-1264, 2009.
 
11) Dillavou E D, et al:Predictors of morbidity and mortality with endovascular and open thoracic aneurysm repair. J Vasc Surg 48:1114-1119, 2008.
PubMed
12) Czerny M, et al:Long-term results of thoracic endovascular aortic repair in atherosclerotic aneurysms involving the descending aorta. J Thorac Cardiovasc Surg 140 (6Suppl):S179-184, 2010.
 
13) Preventza O, et al:Management of endoleaks associated with endovascular treatment of descending thoracic aortic diseases. J Vasc Surg 48:69-73, 2008.
PubMed
14) Morales J P, et al:Endoleaks following endovascular repair of thoracic aortic aneurysm:etiology and outcomes. J Endovasc Ther 15:631-638, 2008.
PubMed
15) Marcheix B, et al:Endovascular repair oftraumatic rupture of the aortic isthmus:midterm results. J Thorac Cardiovasc Surg 132:1037-1041, 2006.
 
P.201 掲載の参考文献
1) Riesenman P J, et al:Thoracic endovascular aortic repair of aortobronchial fistulas. J Vasc Surg 50 (5):992-998, 2009.
PubMed
2) Jonker F H, et al:Outcomes of thoracic endovascular aortic repair for aortobronchial and aortoesophageal fistulas. J Endovasc Ther 16 (4):428-440, 2009.
PubMed
3) Miyata T, et al:Endovascular stent graft repair of aortopulmonary fistula. J Vasc Surg 29 (3):557-560, 1999.
PubMed
4) Karmy-Jones R, et al:Endovascular repair compared with operative repair of traumatic rupture of the thoracic aorta:anonsystematic review and a plea for trauma-specific reporting guidelines. J Trauma 71 (4):1059-1072, 2011.
 
5) Attmann T, et al:Two-stage surgical and endovascular treatment of an aneurysmal aberrant right subclavian (Lusoria) artery. Eur J Cardiothorac Surg 27 (6):1125-1127, 2005.
PubMed
6) Khavandi A, et al:Transcatheter and endovascular stent graft management of coarctation-related pseudoaneurysms. Heart 99 (17):1275-1281, 2013.
PubMed
P.208 掲載の参考文献
1) Hongo N, et al:Endovascular aortic arch reconstruction using in situ stent-graft fenestration in the brachiocephalic artery. J Vasc Interv Radiol 22 (8):1144-1148, 2011.
PubMed
2) Wada T, et al:A new method for protection from shower embolism during TEVAR on a shaggy aorta. Gen Thorac Cardiovasc Surg 2013 (Epub ahead of print).
 
P.221 掲載の参考文献
1) 吉川公彦, 他:腹部大動脈瘤に対するゼニスAAA エンドバスキュラーグラフトの臨床治験成績. 脈管学47:53-63, 2007.
 
2) 循環器病の診断と治療に関するガイドライン (2010年度合同研究班報告)
 
3) Hansen CJ, et al:Complications of en-dovascular repair of high-risk and emergent descending thoracic aortic aneurysms and dissections. J Vasc Surg 40:228-234, 2004.
 
4) Makaroun M S, et al:Gore TAG Investigators. Five-year results of endovascular treatment with the Gore TAG device compared with open repair of thoracic aortic aneurysms. J Vasc Surg 47:912-918, 2008.
PubMed
5) Stone D H, et al:Stent-graft versus open-surgical repair of the thoracic aorta:midterm results. J Vasc Surg 44:1188-1197, 2006.
PubMed
6) Prinssen M, et al:A randomized trial comparing conventional and endovascular repair of abdominal aortic aneurysms. N Engl J Med 351:1607-1618, 2004.
PubMed
7) EVAR Trial Participants. Endovascular aneurysm repalr versus open repair in patients with abdominal aortic aneurysm (EVAR trial 1):randomized controlled trial. Lancet 365:2179-2186, 2005.
PubMed
8) EVAR Trial Participants. Endovascular aneurysm repair and outcome in patients unfit for open repair of abdominal aortic aneurysm (EVAR trial 2):randomized controlled trial. Lancet 365:2187-2192, 2005.
PubMed
9) Higashiura W, et al:Initial experience of branched endovascular graft for abdominal aortic aneurysm with complex anatomy of proximal neck:planning and technical considerations. Jpn J Radio 28:66-74, 2010.
 
10) Kitagawa A, et al:Zenith p-branch standard fenestrated endovascular graft for juxtarenal abdominal aortic aneurysms. J Vasc Surg 58 (2):291-300, 2013.
PubMed
P.231 掲載の参考文献
1) Rigberg D A, et al:Thirty-day mortality statistics underestimate the risk of repair of thoracoabdominal aortic aneurysms:a statewide experience. J Vasc Surg 43:217-223, 2006.
PubMed
2) 大木隆生:手術不能の胸腹部大動脈瘤に対する枝付きステントグラフト術. 日外会誌 112:26-31, 2011.
 
3) 大木隆生:胸腹部大動脈瘤に対する枝付きステントグラフト術:手術不能の壁に挑む. 心臓44:1003-1008, 2012.
 
4) Ferreira M, et al:Branched devices for thoracoabdominal aneurysm repair:Early experience. J Vasc Surg 48:30s-36s, 200&
 
P.238 掲載の参考文献
1) Dake M D, et al:Transluminal placement of endovascular stent-grafts for the treatment of descending thoracic aortic aneurysms, N Engl J Med 331 (26):1729-1734, 1994.
PubMed
2) Gopaldas R R, et al:Superior nationwide outcomes of endovascular versus open repair for isolated descending thoracic aortic aneurysm in 11,669 patients. J Thorac Cardiovasc Surg 140 (5):1001-1010, 2010.
PubMed
3) Kawaguchi S, et al:Thoracic endovascular aneurysm repair in Japan:Experience with fenestrated stent grafts in the treatment of distal arch aneurysms. J Vasc Surg 48 (6 Suppl):24S-29S:discussion 29S, 2008.
 
4) Inoue K, et al:Aortic arch reconstruction by transluminally placed endovascular branched stent graft. Circulation 100 (19 Suppl):II316-321, 1999.
 
5) Criado F J:A percutaneous technique for preservation of arch branch patency during thoracic endovascular aortic repair (TEVAR):retrograde catheterization and stenting. J Endovasc Ther 14 (1):54-58, 2007.
PubMed
6) Ishimaru S, et al:Endografting of the aortic arch. J Endovasc Ther 11 (Suppl II):II-62-71, 2004.
 
7) Morash M D, et al:Subclavian artery transposition and bypass technique for use with endoluminal repair of acute and chronic thoracic aortic pathology. J Vasc Surg 43 (Suppl A):73A-77A, 2006.
 
8) Cooper D G, et al:Neurological complications after left subclavian artery coverage during thoracic endovascular aortic repair:asystematic review and meta-analysis. J Vasc Surg 49 (6):1594-1601, 2009.
 
9) Rizvi A Z, et al:The effect of left subclavian artery coverage on morbidity and mortality in patients undergoing endovascular thoracic aortic interentions:a systematic review and meta-analysis. J Vasc Surg 50:1159-1169, 2009.
 
10) Matsuura J S, et al:Left subclavian artery revascularization:Society for vascular surgery practice guidelines. J Vasc Surg 52 (4Suppl):65S-70S, 2010.
 
11) Shimizu H, et al:Hybrid treatment of a ruptured aneurysm in the distal aortic arch:report of a case. Surgery Today 42 (10):1019-1021, 2012.
PubMed
12) Minatoya K, et al:Evolving selective cerebral perfusion for aortic arch replacement:high flow rate with moderate hypothermic circulatory arrest Ann Thorac Surg 86 (6):1827-1831, 2008.
PubMed
13) Okita Y, et al:Total arch replacement using antegrade cerebral perfusion. J Thorac Cardiovasc Surg 145 (3 Suppl):S63-71, 2013.
 
14) Shimizu H, et al:Total arch replacement under flow monitoring during selective cerebral perfusion using a single pump. Ann Thorac Surg 95 (1):29-34, 2013.
PubMed
15) Szeto W Y, et al:Hybrid repair of aortic arch aneurysm:combined open arch reconstruction and endovascular repair. Seimn Thorac Cardiovasc Surg 21:347-354, 2009.
PubMed
16) Antona C, et al:Hybrid technique for total arch repair:aortic neck reshaping for endovascular-graft fixation, Ann Thorac Surg 83 (3):1158-1161, 2007
PubMed
17) Shimizu H, et al:Thoracic endovascular aortic repair in patients with prior open aortic surgery. Ann Vasc Des 6 (1):80-83, 2013.
 
18) Flores J, et al:Extensive deployment of the stented elephant trunk with associated with an increased risk of spial cord injury. J Thorac Cardiovasc Surg 131 (2):336-342, 2006.
 
19) Koullias G J, et al:State-of-the-art of hybrid procedures for the aortic arch:a metaanalysis. Ann Thorac Surg 90 (2):689-697, 2010.
PubMed
P.242 掲載の参考文献
1) Amano J, et al:Thoracic and cardiovascular surgery in Japan during 2011:Annual report by The Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg 2013 Aug 30.
 
2) Ueda Y, et al:Surgical treatment of aneurysm or dissection involving the ascending aorta and aortic arch, utilizing circulatory arrest and retrograde cerebral perfusion. J Cardiovasc Surg (Torino) 31:553-558, 1990.
 
3) Kazui T, et al:Improved results of athero sclerotic arch aneurysm operations with a refined technique. J Thorac Cardiovasc Surg 121:491-499, 2001.
 
4) Okita Y, et al:Prospective comparative study of brain protection in total aortic arch replacement:deep hypothermic circulatory arrest with retrograde cerebral perfusion or selective antegrade cerebral perfusion. Ann Thorac Surg 72:72-79, 2001.
 
5) Okada K, et al:Recent advancements of total aortic arch replacement. J Thorac Cardiovasc 144:139-145, 2012.
PubMed
6) Okita Y, et al:Total arch replacement using antegrade cerebral perfusion. JThorac Cardiovasc Surg 145:S63-71, 2013.
PubMed
7) Patel H J, et al:Open arch reconstruction in the endovascular era:analysis of 721 patient over 17 years. J Thorac Cardiovasc Surg 141:1417-1423, 2011.
PubMed
8) Shimizu H, et al:Total arch replacement under flow monitoring during selective cerebral perfusion using a single pump. Ann Thorac Surg 95:29-35, 2013.
PubMed
9) Iba Y, et al:Contemporary open aortic arch repair with selective cerebral perfusion in the era of endovascular aortic repair. J Thorac Cardiovasc Surg 445:S72-77, 2013.
 
10) Suzuki T, et al:Selective cerebral perfusion with mild hypothermic lower body circulatory arrest is safe for arotic arch surgery. Eur J Cardiothorac Surg 43:94-98, 2013.
 
11) Kurimoto Y, et al:Management of left subclavian artery in endovascular stent-grafting for distal aortic arch disease. Circ J 72 (3):449-453, 2008.
PubMed
12) Inoue K, et al:Aortic arch reconstruction by transluminally placed endovascular branched stent graft Circulation 100 (19 Suppl):II316-321, 1999.
 
13) Cires G, et al:Endovascular debranching of the aortic arch during thoracic endograft repair. Vasc Surg 53 (6):1485-1491, 2011.
PubMed
14) Vallejo N, et al:Hybrid repair of thoracic aortic lesions for zone 0 and 1 in high-risk patients. J Vasc Surg 55 (2):318-325, 2012.
 
15) Hogendoorn W, et al:Thoracic endovascular aortic repair with the chimney graft technique. J Vasc Surg 58 (2):502-511, 2013.
PubMed
16) Cao P, et al:Systematic review of clinical outcomes in hybrid procedures for aortic arch dissections and other arch diseases. J Thorac Cardiovasc Surg 144 (6):1286-1300, 2012.
PubMed
17) Cheng D, et al:Endovascular aortic repair versus open surgical repair for descending thoracic aortic disease a systematic review and meta-analysis of comparative studies. Am Coll Cardiol 55 (10):986-1001, 2010.
PubMed
18) Frederik H, et al:Meta-analysis of open versus endovascular repair for ruptured descending thoracic aortic aneurysm. J Vasc Surg 51:1026-1032, 2010.
 
19) Patel VI, et al:Impact of hospital volume and type on outcomes of open and endovascular repair of descending thoracic aneurysms in the United States Medicare population. J Vasc Surg 58 (2):346-354, 2013.
PubMed
20) LeMaire S A, et al:Results of open thoracoabdominal aortic aneurysm repair. Ann Cardiothorac Surg 1 (3):286-292, 2012.
PubMed
21) Liao J M, et al:Nationwide trends and regional/hospital variations in open versus endovascular repair of thoracoabdominal aortic aneurysms. J Thorac Cardiovasc Surg 144:612-616, 2012.
PubMed
22) Hughesl G C, et al:Thoracoabdominal aortic aneurysm:hybrid repair outcomes. Ann Cardiothorac Surg 1 (3):311-319, 2012.
 
23) L. de la Motte, et al:Outcomes After Elective Aortic Aneurysm Repair:A Nationwide DanishCohort Study 2007-2010. Eur J Vasc Endovasc Surg 46(1):57-64, 2013.
 
24) Mohan P P, et al:Comparison of Endovascular and Open Repair of Ruptured Abdominal Aortic Aneurysm in the United States in the Past Decade. Cardiovasc Intervent Radiol 2013.
PubMed
P.252 掲載の参考文献
1) McKusick V A:The Cardiovascular Aspects of Marfan's Syndrome:A Heritable Disorder of Connective Tissue. Circulation 11:321-342, 1955.
PubMed
2) Dietz H C, et al:Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 352:337-339, 1991.
PubMed
3) De Paepe A, et al:Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 62:417-426, 1996.
PubMed
4) Loeys B L, et al:The revised Ghent nosology for the Marfan syndrome. J Med Genet 47:476-485, 2010.
PubMed
5) Salim M A, et al:Effect of beta-adrenergic blockade on aortic root rate of dilatation in the Marfan syndrome. Am J Cardiol 74:629-633, 1994.
PubMed
6) Habashi J p, et al:Losartan, an ATI antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312:117-121, 2006.
 
7) Brooke B S, et al:Angiotensin II Blockade and Aortic-Root Dilatation in Marfan's Syndrome. N Engl J Med 358:2787-2795, 2008.
PubMed
8) Faivre L, et al:Effect of mutation type and location on clinical outcome in 1,013 probands with marfan syndrome or related phenotypes and FBNI mutations:An international study. Am J Hum Genet 81:454-466, 2007
PubMed
P.261 掲載の参考文献
1) Judge D P, et al:Marfan's syndrome. Lancet 366:1965-1976, 2005.
PubMed
2) Murdoch J L, et al:Life expectancy and causes of death in the Marfan syndrome. N Engl J Med 286:804-808, 1972.
PubMed
3) Bentall H, et al:Atechnique for complete replacement of the ascending aorta. Thorax 23:338-339, 1968.
 
4) David T E, et al:An aortic valve-sparing operation for patients with aortic incompetence and aneurysm of the ascending aorta J Thorac Cardiovasc Surg 103:617-921, discussion 22, 1992.
 
5) Sarsam M A, et al:Remodeling of the aortic valve anulus. J Thorac Cardiovasc Surg 105:435-438, 1993.
PubMed
6) Hvass U:A new technique for sparing the aortic valve in patients with aneurysm of the ascending aorta and root. J Thorac Cardiovasc Surg 119:1048-1049, 2000.
 
7) Lansac E, et al:External aortic annuloplasty ring for valve-sparing Procedures. Ann Thorac Surg 79:356-358, 2005.
PubMed
8) Silverman D I, et al:Life expectancy in the Marfan syndrome. Am J Cardiol 75:157-160, 1995.
PubMed
9) 宮入剛:胸部大動脈瘤の手術適応と術式新・心臓病診療プラクティス血管疾患を診る・治す (小室一成 編), p145-152, 文光堂, 東京, 2010.
 
10) Sakata R, et al:Thoracic and cardiovascular surgery in Japan during 2008:Annual report by The Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg 58:356-383, 2010.
PubMed
11) Ades L:Guidelines for the diagnosis and management of Marfan syndrome. Heart Lung Circ 16 (1):28-30, 2007.
PubMed
12) Nienaber C A, et al:Strategies for subacute/chronic type B aortic dissection:the Investigation Of Stent Grafts in Patients with type B Aortic Dissection (INSTEAD) trial 1-year outcome. J Thorac Cardiovasc Surg 140:S101-108 discussion:S142-146, 2010.
 
13) Pacini D, et al:Endovascular treatment for type B dissection in Marfan syndrome:is it worthwhile? Ann Thorac Surg 95 (2):737-749, 2013.
PubMed

第5章 ガイドライン

P.268 掲載の参考文献
1) 大動脈瘤・大動脈解離診療ガイドライン (2011年改訂版) http://www.j-circ.or.jp/guideline/pdf/JCS2011_takamoto_h.pdf
 
2) 大動脈瘤・大動脈解離診療ガイドライン (2006年改訂版). Circ J 70 (suppl IV):1569-1646, 2006.
 
3) Vilacosta I, et al:Natural history and serial morphology of aortic intramural hematoma; a novel variant of aortic dissection. Am Heart J 134:495-507, 1997.
PubMed
4) Hiratzka L F, et al:2010 ACCF/AHA/ AATS/ACR/ASA/SCA/SCAI/SIR/STS/ SVM guidelines for the diagnosis and management of patients with thoracic aortic disease. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. J Am Coll Cardiol 55:e27-129, 2010,
 
5) Loeys B L, et al:The revised Ghent nosology for the Marfan syndrome. J Med Genet 47:476-485, 2010.
PubMed

書評

最近チェックした商品履歴

Loading...